Company Filing History:
Years Active: 2016-2017
Title: Linda Havdalen: Innovator in Endonuclease Technology
Introduction
Linda Havdalen is a prominent inventor based in Tromsø, Norway. She has made significant contributions to the field of biotechnology, particularly in the development of endonucleases. With a total of 2 patents to her name, her work has the potential to impact various applications in molecular biology.
Latest Patents
Linda's latest patents focus on endonucleases, specifically providing an endonuclease I or enzymatically active fragment thereof. The invention details that the endonuclease I has the sequence of SEQ ID No. 4 or a sequence that is at least 70% identical to it. Additionally, it describes a modification where the amino acid residue immediately N-terminal of the FYCGC pentapeptide motif has been substituted with a negatively charged residue. This innovation also includes nucleic acid molecules encoding these enzymes and methods for removing contaminating polynucleotides from a sample using these enzymes.
Career Highlights
Linda Havdalen is currently associated with Biotec Pharmacon ASA, where she continues to advance her research in biotechnology. Her work has garnered attention for its innovative approach to enzyme technology, which is crucial for various scientific applications.
Collaborations
Throughout her career, Linda has collaborated with notable colleagues, including Olav Lanes and Terese Solstad. These partnerships have contributed to her success and the advancement of her research projects.
Conclusion
Linda Havdalen stands out as an influential inventor in the field of endonuclease technology. Her contributions are paving the way for advancements in molecular biology and biotechnology.